With a combined analysis (n = 115) of four publicly available RNA sequencing (RNA-seq) datasets from various cancer types (34–37), we found that high pretreatment expression of UBA1 was strongly predictive of ICB resistance (P = 0.009; Fig. 1G). The gene discussed is UBA1; the disease is cancer.